Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Validea Market Legends ETF VALX Mar 24, 2017 0.26 0.00   
 Valley Financial Corp VYFC Mar 24, 2017 21.36 0.00   
 Valley National Bancorp VLYWW Mar 24, 2017 0.03 0.00   
 Value Line VALU Mar 24, 2017 17.23 -2.24   
 Valueclick Inc VCLK Mar 24, 2017 21.00 0.00   
 Valuevision Media VVTV Mar 24, 2017 6.08 0.00   
 Vanda Pharmaceuticals Inc VNDA Mar 24, 2017 14.45 +2.48   
 VanEck Vectors Biotech ETF BBH Mar 24, 2017 117.80 +0.56   
 VanEck Vectors Generic Drugs ETF GNRX Mar 24, 2017 22.64 +0.37   
 VanEck Vectors Pharmaceutical ETF PPH Mar 24, 2017 55.17 -0.18   
 Vanguard Emerging Markets Gover VWOB Mar 24, 2017 79.45 +0.01   
 Vanguard International Dividend Appreciation ETF VIGI Mar 24, 2017 57.34 +0.33   
 Vanguard International High Dividend Yield ETF VYMI Mar 24, 2017 60.56 +0.28   
 Vanguard Natural Resources LLC VNRCP Mar 24, 2017 2.00 0.00   
 Vanguard Natural Resources LLC VNRBP Mar 24, 2017 2.00 0.00   
 Vanguard Natural Resources Llc VNR Mar 24, 2017 0.20 0.00   
 Vanguard Natural Resources Llc Pfd. Series A VNRAP Mar 24, 2017 2.26 0.00   
 Vanguard Short-Term Inflation-P VTIP Mar 24, 2017 49.38 -0.08   
 Vanguard Total International Bo BNDX Mar 24, 2017 54.02 +0.09   
 Varonis Systems, Inc. VRNS Mar 24, 2017 30.95 +0.81   
 Vasco Data Security International VDSI Mar 24, 2017 12.90 +0.78   
 Vascular Biogenics Ltd. VBLT Mar 24, 2017 5.65 +1.80   
 Vascular Solutions VASC Mar 24, 2017 56.00 0.00   
 VBI Vaccines, Inc. VBIV Mar 24, 2017 5.16 -0.19   
 Vca Antech WOOF Mar 24, 2017 91.50 -0.09   
 Vcg Holding Corp. VCGH Mar 24, 2017 2.24 0.00   
 Veeco Instruments Inc VECO Mar 24, 2017 28.75 -0.17   
 Velocityshares Emerging Asia Dr ASDR Mar 24, 2017 68.90 0.00   
 Velocityshares Emerging Markets EMDR Mar 24, 2017 49.28 0.00   
 Velocityshares Equal Risk Weigh ERW Mar 24, 2017 49.00 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK